← Back to Search

HypErthermia as an Additional Treatment for the Biology and Experience of Depression (HEATBED Trial)

N/A
Waitlist Available
Led By Frederick M Hecht, MD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tested the combination of a heat treatment and a type of talk therapy in adults with major depressive disorder. The heat treatment uses heat to potentially boost mood, while the talk therapy helps change negative thoughts. The goal is to find more effective and well-tolerated treatments for depression.

Eligible Conditions
  • Depression

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average Number of Planned WBH Sessions Completed
Secondary study objectives
Average Number of Planned Beck Depression Inventory-II (BDI-II) Assessments Completed
Change in Beck Depression Inventory-II (BDI-II) From Baseline to 12-week Assessment

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive Behavioral Therapy (CBT) and Whole-Body Hyperthermia (WBH)Experimental Treatment2 Interventions
Participants receive up to 8 weekly (early phase) or 4 bi-weekly (later phase) whole-body hyperthermia (WBH) sessions and 8 weekly cognitive behavioral therapy (CBT) sessions. Each WBH session (including preparation and cool down) is up to approximately 3.5-4 hours, and each CBT session is approximately 50 minutes.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Whole-Body Hyperthermia (WBH)
2021
N/A
~20
Cognitive Behavioral Therapy (CBT)
2008
Completed Phase 4
~3620

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,591 Previous Clinical Trials
14,901,625 Total Patients Enrolled
74 Trials studying Depression
26,540 Patients Enrolled for Depression
National Center for Complementary and Integrative Health (NCCIH)NIH
862 Previous Clinical Trials
674,085 Total Patients Enrolled
65 Trials studying Depression
33,375 Patients Enrolled for Depression
Frederick M Hecht, MDPrincipal InvestigatorUniversity of California, San Francisco
3 Previous Clinical Trials
170 Total Patients Enrolled
1 Trials studying Depression
30 Patients Enrolled for Depression
Ashley E Mason, PhDPrincipal InvestigatorUniversity of California, San Francisco
5 Previous Clinical Trials
210 Total Patients Enrolled
1 Trials studying Depression
30 Patients Enrolled for Depression
~4 spots leftby Dec 2025